Report Diabetic Ketoacidosis in a Patient With Type I Diabetes Treated With a Closed-Loop Sensor-Augmented Insulin Infusion System

被引:4
|
作者
Sharma, Pranjali P. [1 ]
-Berlioz, Ana M. Ramirez
Weisz, Angela D. [2 ]
机构
[1] Parkview Hlth Syst, Dept Endocrinol, 4722 Eagleridge Circle, Pueblo, CO 81008 USA
[2] Parkview Hlth Syst, Pueblo, CO USA
来源
AACE CLINICAL CASE REPORTS | 2023年 / 9卷 / 04期
关键词
DKA; type 1 diabetes mellitus; diabetes technology; closed -loop insulin infusion system; tirzepatide;
D O I
10.1016/j.aace.2023.04.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Objective: Closed-loop insulin infusion systems (CLSs) such as Tandem t:slim with Control-IQ (t:slim CIQ) improve glycemic control and decrease diabetic ketoacidosis (DKA) risk in type 1 diabetes mellitus (T1DM). We report a case of CLS failure, likely from tirzepatide-induced volume depletion, leading to DKA. Case Report: A 36-year-old woman with T1DM on t:slim CIQ CLS was prescribed tirzepatide for weight loss. Three months later, 4 days after the last tirzepatide injection, she presented with worsening nausea, vomiting, 50-lbs weight loss, minimal oral intake for 3 days, and positive urine ketone result. Her heart rate was 137 beats/min and respiratory rate was 35 breaths/min, and she had Kussmaul breathing, with dry oral mucosa indicating volume depletion. Laboratory examination showed a fingerstick glucose level of 289 mg/dL, serum glucose level of 322 mg/dL, bicarbonate level of 12 mmol/L, and anion gap of 21 mmol/L confirming high-anion-gap metabolic acidosis, suggesting DKA. A concurrent continuous glucose monitor (CGM) reading was 40 mg/dL. The CLS and CGM were removed. DKA resolved within 72 hours (serum glucose level of 143 mg/dL, anion gap of 8 mmol/L, bicarbonate level of 24 mmol/L) on intravenous insulin and fluids. The CLS and CGM were restarted with good glycemic control. Tirzepatide was discontinued to avoid future episodes of volume depletion. Discussion: Volume depletion affects interstitial fluid glucose levels due to compensatory mechanisms. This may result in CLS failure due to CGM dependence on interstitial glucose measurements, precipitating DKA. Conclusion: Patients on CLS therapy should be cautioned against CLS failure in volume-depleted states with interstitial glucose-level changes. A back-up plan with multiple daily insulin injections should be discussed. (c) 2023 AACE. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:116 / 121
页数:6
相关论文
共 50 条
  • [41] The Effect of a Closed-Loop Insulin Delivery System on Glycemic Control in Type 1 Diabetes
    Koutsovasilis, Anastasios
    Sotiropoulos, Alexios
    Antoniou, Anastasia
    Kordinas, Vasilios
    Papadaki, Despina
    Peppas, Theodoros
    DIABETES, 2019, 68
  • [42] Insulin pump therapy and glucose control during Ramadan fasting in an adolescent with type 1 diabetes: from an open-loop sensor-augmented pump therapy with predictive low-glucose management to an advanced hybrid closed-loop system
    Selmen Wannes
    Dhai Al Qusayer
    Sameh El Abed
    Manel Ben Fredj
    Acta Diabetologica, 2023, 60 : 851 - 855
  • [43] Changes to insulin pump settings throughout pregnancy for individuals using assisted hybrid closed-loop therapy versus sensor-augmented pump therapy
    King, Jocelynn
    Buschur, Elizabeth
    Garcetti, Rachel
    Pyle, Laura
    Sakamoto, Casey
    Snell-Bergeon, Janet
    Nease, Emily
    Bartholomew, Anna
    Dungan, Kathleen
    Polsky, Sarit
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2025, 39 (04)
  • [44] Day and Night Closed-Loop Control in Adults With Type 1 Diabetes A comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management
    Luijf, Yoeri M.
    DeVries, J. Hans
    Zwinderman, Koos
    Leelarathna, Lalantha
    Nodale, Marianna
    Caldwell, Karen
    Kumareswaran, Kavita
    Elleri, Daniela
    Allen, Janet M.
    Wilinska, Malgorzata E.
    Evans, Mark L.
    Hovorka, Roman
    Doll, Werner
    Ellmerer, Martin
    Mader, Julia K.
    Renard, Eric
    Place, Jerome
    Farret, Anne
    Cobelli, Claudio
    Del Favero, Simone
    Dalla Man, Chiara
    Avogaro, Angelo
    Bruttomesso, Daniela
    Filippi, Alessio
    Scotton, Rachele
    Magni, Lalo
    Lanzola, Giordano
    Di Palma, Federico
    Soru, Paola
    Toffanin, Chiara
    De Nicolao, Giuseppe
    Arnolds, Sabine
    Benesch, Carsten
    Heinemann, Lutz
    DIABETES CARE, 2013, 36 (12) : 3882 - 3887
  • [45] Effect of an Insulin Infusion Site Warming Device on Insulin Pharmacokinetics in a Closed-Loop System
    Patel, Neha S.
    Weinzimer, Stuart A.
    Bitton, Gabby
    Grosman, Benyamin
    Sherr, Jennifer L.
    Michaud, Camille
    Tichy, Eileen
    Carria, Lori
    Tamborlane, William V.
    Cengiz, Eda
    DIABETES, 2015, 64 : A276 - A277
  • [46] Insulin pump therapy and glucose control during Ramadan fasting in an adolescent with type 1 diabetes: from an open-loop sensor-augmented pump therapy with predictive low-glucose management to an advanced hybrid closed-loop system
    Wannes, Selmen
    Al Qusayer, Dhai
    El Abed, Sameh
    Ben Fredj, Manel
    ACTA DIABETOLOGICA, 2023, 60 (06) : 851 - 855
  • [47] DIABETIC KETOACIDOSIS AFTER INITIATION OF SGLT-INHIBITION UNDER HYBRID CLOSED-LOOP THERAPY IN TYPE 1 DIABETES
    Visser, M.
    Mathieu, C.
    Gillard, P.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A58 - A58
  • [48] Provider Time Associated with Sensor-Augmented Insulin Pump Therapy in Type 1 Diabetes
    Kamble, Shital
    Perry, Brenda M.
    Shafiroff, Jeff
    Schulman, Kevin A.
    Reed, Shelby D.
    DIABETES, 2011, 60 : A238 - A238
  • [49] The Closed-Loop System Improved the Control of a Pregnant Patient with Type 1 Diabetes Mellitus
    Guzman Gomez, Guillermo E.
    Viggiano, Julian A.
    Silva-De las Salas, A.
    Martinez, Veline
    Urbano Bonilla, Maria A.
    CASE REPORTS IN ENDOCRINOLOGY, 2021, 2021
  • [50] Overnight Closed-Loop Insulin Delivery in Patients with Type 1 Diabetes
    Wilinska, M. E.
    Allen, J. M.
    Elleri, D.
    Kumareswaran, K.
    Nodale, M.
    Evans, M. L.
    Dunger, D. B.
    Hovorka, R.
    5TH EUROPEAN CONFERENCE OF THE INTERNATIONAL FEDERATION FOR MEDICAL AND BIOLOGICAL ENGINEERING, PTS 1 AND 2, 2012, 37 : 961 - 963